In 2018 Avalon Pharma showed a growth rate of 5.9% relative to a market decline of -1.5%.

In 2018 Avalon Pharma grew to becoming the 13th largest pharmaceutical company in the Kingdom

Corporate Governance


The key aspects of Avalon Pharma’s governance are integrity, sustainable business practices, customer focused outlook, and strong leadership to manage a high-growth working environment Avalon Pharma is a process driven corporation that is able to execute projects via faster decision-making. Company is managed by the Executive Committee with constant guidance from the Board of Directors. Responsibilities are defined, and cross-functional interactions are encouraged for effective governance. 

2018 Financials

Looking for more information? 

We are here to assist. Contact us by phone, email or via our social media channels.

© 2019 by Avalon Pharma

  • Black Instagram Icon
  • Black Facebook Icon
  • Linkdein